CureSureMedico
Currency

Multiple Sclerosis & Movement Disorder Treatment

Neurology

payments

Starting from

$5,000

Up to $30,000 depending on centre

schedule

Typical duration

10–30 days

Including pre-operative work-up

medical_services

Procedures

4

Hold to see procedures

arrow_downwardlocal_hospital

Partner hospitals

0

Vetted for outcome data & accreditation

Overview

Receive expert neurological assessment and access to the latest disease-modifying therapies (DMTs), infusion treatments, and specialist care for multiple sclerosis, Parkinson's disease, and other movement disorders. Leading neurology centers in India and Israel offer internationally accredited MS clinics and movement disorder programs at significantly reduced costs.

Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.

What's included

Comprehensive neurological assessment and diagnosis review
MRI brain and spine imaging with specialist reporting
DMT infusion or HSCT procedure as indicated
Inpatient monitoring and nursing care during treatment
Patient coordinator, interpreter, and care navigation
Detailed discharge plan with home-country neurologist liaison

Coordinated from

$5,000

or message us on WhatsApp

No commitment required. Your data is never shared with third parties.

Global cost comparison — Multiple Sclerosis & Movement Disorder Treatment

Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.

CountryAvg. cost
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Best value
$6,000
🇹🇷

Turkey

Istanbul

$18,750

Costs are indicative and reviewed quarterly. Request a personalised estimate for your specific case.

Frequently asked questions

Yes — this is one of the most common reasons MS patients seek care internationally. Countries like India and Turkey have access to approved DMTs (including natalizumab, ocrelizumab, and alemtuzumab) at 40–70% lower cost than in the US, UK, or Africa. Some treatments like HSCT for MS are also available in accredited centers in India and Turkey but remain experimental or inaccessible in many countries. Our coordinators will review your current diagnosis, MRI reports, and treatment history to match you with the most appropriate center and treatment protocol.

No fees. No commitment.

Our guidance is completely free

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp